UNIVERSITY OF QUEENSLAND Researchers have identified a major shift in how to treat brain injuries, after rejuvenating immune cells to support the repair process. The University of Queensland study focused on the brain’s learning and memory centre, the hippocampus, and its unique ability to produce new brain nerve cells during adult life, which is critical...
Month: <span>March 2020</span>
Post
Tivic Wins EU Clearance for ClearUP Sinus Relief Device
CICI ZHOU ENT San Francisco-based Tivic Health announced that the company has received CE Mark approval in Europe for ClearUP Sinus Pain Relief, a small handheld device that can temporarily relieve allergy-related sinus pain, pressure, and congestion. ClearUP is a small handheld device that delivers a proprietary microcurrent waveform that stimulates sinus nerve fibers under...
Post
Two weeks after sports-related concussion, most patients have not recovered
Recovery may be slower than current guidelines state, reports Clinical Journal of Sport Medicine WOLTERS KLUWER HEALTH Less than half of patients with sports-related mild traumatic brain injury (mTBI) achieve clinical recovery within two weeks after injury, reports a study in Clinical Journal of Sport Medicine. The journal is published in the Lippincott portfolio by...
Post
Why does the coronavirus spread so easily between people?
Researchers have identified microscopic features that could make the pathogen more infectious than the SARS virus — and serve as drug targets. As the number of coronavirus infections approaches 100,000 people worldwide, researchers are racing to understand what makes it spread so easily. A handful of genetic and structural analyses have identified a key feature...
Post
‘Real-World’ Data from Health Systems Reveal Opportunities for Blood Pressure Improvement
Uncontrolled blood pressure is the leading cause of preventable death in the United States even though existing medications, when prescribed and taken according to guidelines, work well. According to a new analysis of electronic health records (EHRs) led by a UC San Francisco scientist, as many as 40 percents of the roughly 80 million Americans...
Post
New study on COVID-19 estimates 5.1 days for incubation period
by Johns Hopkins University Bloomberg School of Public Health An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new study led by researchers at Johns Hopkins Bloomberg School of Public...
Post
Modern virtual and augmented reality device can help simulate sight loss
Virtual/augmented reality devices can simulate some of the key difficulties experienced due to glaucoma, suggests new study from City, University of London. CITY UNIVERSITY LONDON Published today, during World Glaucoma Week 2020, a new study demonstrates how commercially available head mounted displays (HMD) can be used to simulate the day-to-day challenges faced by people with...
Post
Tomosynthesis outperforms digital mammography in five-year study
RADIOLOGICAL SOCIETY OF NORTH AMERICA OAK BROOK, Ill. – A new study published in the journal Radiology has found that the advantages of digital breast tomosynthesis (DBT) over digital mammography (DM), including increased cancer detection and fewer false positive findings, are maintained over multiple years and rounds of screening. In addition, research showed that DBT...
Post
Coronavirus: Can S. Korea be a model for virus-hit countries?
A rapid surge in coronavirus cases saw South Korea become one of the world’s worst-affected countries outside China, but it has since cut infection rates significantly and has one of the lowest fatality rates anywhere. This transmission electron microscope image shows SARS-CoV-2 — also known as 2019-nCoV, the virus that causes COVID-19 — isolated from...
Post
ClotChip Receives FDA Breakthrough Device Designation for Real-Time Coagulation Testing
CICI ZHOU CARDIOLOGY, MEDICINE Cleveland-based XaTek Inc. announced receiving FDA Breakthrough Device designation for ClotChip, a handheld device that can measure a patient’s bleeding risk profile from a single drop of blood. The main advantage of ClotChip is that it produces results in 15 minutes, versus the many hours that traditional lab work currently takes....